Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
40.4M
-
Shares change
-
-630K
-
Total reported value, excl. options
-
$124M
-
Value change
-
-$2.17M
-
Put/Call ratio
-
0.07
-
Number of buys
-
28
-
Number of sells
-
-44
-
Price
-
$3.07
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2020
95 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q3 2020.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.4M shares
.
Largest 10 shareholders include NEA Management Company, LLC (9.09M shares), BVF INC/IL (7.24M shares), EcoR1 Capital, LLC (3.73M shares), WELLINGTON MANAGEMENT GROUP LLP (3.68M shares), BlackRock Inc. (2.93M shares), Camber Capital Management LP (2.5M shares), Camber Capital Management LP (2.5M shares), DIMENSIONAL FUND ADVISORS LP (1.2M shares), STATE STREET CORP (672K shares), and GEODE CAPITAL MANAGEMENT, LLC (605K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.